FDA warning letters decline by 50%

06/8/2008 | Wall Street Journal, The

The number of warning letters the FDA sent to companies dropped from 1,032 in 2001 to 471 in 2007, following a 2002 policy change requiring the agency's chief counsel office to review such documents. FDA Commissioner Andrew von Eschenbach acknowledged the drop but argued that the agency now issues letters for serious transgressions instead of minor ones.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA